Literature DB >> 21360309

Resection of a transplantable single-nodule hepatocellular carcinoma in Child-Pugh class A cirrhosis: factors affecting survival and recurrence.

Fabrice Muscari1, Bertrand Foppa, Nicolas Carrere, Nassim Kamar, Jean-Marie Peron, Bertrand Suc.   

Abstract

BACKGROUND: The aim of this study was to estimate the survival rates and define risk factors for tumor recurrence after resection surgery for single hepatocellular carcinomas (HCCs)≤5 cm (on preoperative imaging) that developed on compensated cirrhosis.
METHODS: A retrospective review studied patients treated by surgical resection. Overall survival (OS), disease-free survival (DFS), recurrence rates, and risk factors were studied for all patients.
RESULTS: A total of 49 patients were treated by resection. The 5-year OS and DFS rates were 52 and 41%, respectively, after 2000. Three independent risk factors were found for OS and DFS: macroscopic vascular invasion, satellite nodules, R1 resection. In the absence of these three factors, the 5-year OS was 59%. Recurrence rates were 63%. Delayed recurrence was significantly related to the 5-year OS. One factor was correlated with early recurrence: the presence of satellite nodules; and one factor was correlated with late recurrence: hepatitis C virus infection.
CONCLUSIONS: R0 resection for HCC on compensated cirrhosis may offer good long-term survival in the absence of satellites nodules and macrovascular invasion. Thus, a "first approach" resection is proposed with the possibility of "salvage transplantation." In other cases, resection may be a bridge to transplantation ("transplantation de principe").

Entities:  

Mesh:

Year:  2011        PMID: 21360309     DOI: 10.1007/s00268-011-1000-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  49 in total

1.  Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.

Authors:  S Jonas; W O Bechstein; T Steinmüller; M Herrmann; C Radke; T Berg; U Settmacher; P Neuhaus
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

2.  Risk factors for early recurrence of small hepatocellular carcinoma after curative resection.

Authors:  Yan-Ming Zhou; Jia-Mei Yang; Bin Li; Zheng-Feng Yin; Feng Xu; Bin Wang; Wen Xu; Tong Kan
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2010-02

3.  Primitive liver cancers: epidemiology and geographical study in France.

Authors:  Frédéric Borie; Brigitte Trétarre; Anne-Marie Bouvier; Jean Faivre; Florence Binder; Guy Launoy; Patricia Delafosse; Jacques Tissot; Jun Peng; Pascale Grosclaude; Anne-Valérie Guizard; Claudine Gras-Aygon
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-09       Impact factor: 2.566

4.  Hepatic resection for hepatocellular carcinoma. An audit of 343 patients.

Authors:  E C Lai; S T Fan; C M Lo; K M Chu; C L Liu; J Wong
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

Review 5.  Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma.

Authors:  W H Caselmann; M Alt
Journal:  J Hepatol       Date:  1996       Impact factor: 25.083

6.  Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis.

Authors:  Steven C Cunningham; Susan Tsai; Hugo P Marques; Paulo Mira; Andrew Cameron; Eduardo Barroso; Benjamin Philosophe; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2009-03-07       Impact factor: 5.344

Review 7.  Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation.

Authors:  E Mor; R Tur-Kaspa; P Sheiner; M Schwartz
Journal:  Ann Intern Med       Date:  1998-10-15       Impact factor: 25.391

8.  Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver.

Authors:  Marco Vivarelli; Alfredo Guglielmi; Andrea Ruzzenente; Alessandro Cucchetti; Roberto Bellusci; Claudio Cordiano; Antonino Cavallari
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

9.  Predictors and patterns of recurrence after resection of hepatocellular carcinoma.

Authors:  Charles Cha; Yuman Fong; William R Jarnagin; Leslie H Blumgart; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2003-11       Impact factor: 6.113

10.  Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection.

Authors:  Honsoul Kim; Mi-Suk Park; Young Nyun Park; Hyunki Kim; Kyung Sik Kim; Jin Sub Choi; Sang Hoon Ahn; Kwang-Hyub Han; Myeong-Jin Kim; Ki Whang Kim
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

View more
  8 in total

Review 1.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

2.  Clinicopathological predictors of poor survival and recurrence after curative resection in hepatocellular carcinoma without portal vein tumor thrombosis.

Authors:  Li Zhou; Jing-An Rui; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu
Journal:  Pathol Oncol Res       Date:  2014-06-08       Impact factor: 3.201

3.  High Levels of Gamma-Glutamyl Transferase and Indocyanine Green Retention Rate at 15 min as Preoperative Predictors of Tumor Recurrence in Patients With Hepatocellular Carcinoma.

Authors:  Peipei Song; Yoshinori Inagaki; Zhigang Wang; Kiyoshi Hasegawa; Yoshihiro Sakamoto; Junichi Arita; Wei Tang; Norihiro Kokudo
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

4.  Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma.

Authors:  Jia-Hong Wang; Wei Wei; Jing Xu; Zhi-Xing Guo; Cheng-Zuo Xiao; Yong-Fa Zhang; Pei-En Jian; Xiao-Liang Wu; Ming Shi; Rong-Ping Guo
Journal:  Oncotarget       Date:  2015-10-27

5.  Model to Predict Overall Survival in Patients With Hepatocellular Carcinoma After Curative Hepatectomy.

Authors:  Li-Xiang Zhang; Pan-Quan Luo; Lei Chen; Dong-da Song; A-Man Xu; Peng Xu; Jia Xu
Journal:  Front Oncol       Date:  2021-03-05       Impact factor: 6.244

6.  Impact of prognostic nutritional index on the recurrence of hepatocellular carcinoma after a curative resection.

Authors:  Ho Jeong; Kil Hwan Kim; Sungho Jo; Sanghyun Song
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-11-30

7.  The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma.

Authors:  Shan-Shan Jiang; De-Sheng Weng; Long Jiang; Yao-Jun Zhang; Ke Pan; Qiu-Zhong Pan; Chang-Long Chen; Jing-Jing Zhao; Xiao-Fei Zhang; Hong-Xia Zhang; Yan Tang; Zi-Qi Zhou; Min-Shan Chen; Jian-Chuan Xia
Journal:  J Cancer       Date:  2016-03-20       Impact factor: 4.207

8.  AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma.

Authors:  Qing Zhu; Yarui Ma; Junbo Liang; Zhewen Wei; Mo Li; Ying Zhang; Mei Liu; Huan He; Chunfeng Qu; Jianqiang Cai; Xiaobing Wang; Yixin Zeng; Yuchen Jiao
Journal:  Signal Transduct Target Ther       Date:  2021-08-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.